Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2010-02-10 09:10:21 |
Versijas komentārs | |
Teksts |
Olaine, February 10, 2010
Preliminary figures show Olainfarm’s sales to Russia
increased by 32.3% in 2009
Sales of Olainfarm to Russia in 2009 have increased by
32.3% compared to 2008, Valerijs Maligins, Chairman of company’s
Board informed. In 2009 Olainfarm sales to Russia were 7.3 million
lats (10.4 million euros).
“Last year Olainfarm exported 87% of its sales.
Russia is our major export market, and about 42% of sales
were made there for a total value of about 10 million lats. Yet in
2003 we only sold 2.2 million there, “ Maligins adds.
We hereby remind you that full unaudited financial
report for 2009 will be published in last week of
February.
JSC Olainfarm is one of the biggest companies in the
Baltic States with more than 35 years of experience in
production of medicines and chemical and pharmaceutical products.
The basic principle of Company's operations is to produce reliable
and effective top quality products for Latvia and the rest of the
world. Currently the products of JSC Olainfarm are being
exported to more than 30 countries worldwide, including the
Baltics, Russia, CIS, Scandinavian and other Western European
countries, Asia and the USA.
Information prepared by
Salvis Lapins
JSC "Olainfarm"
Deputy CFO
tel. +371 6 7013717,
cell: + 371 2 6448873
fax. + 371 6 7013777
|
Pielikumi |
|